2[2]Kulow BF, Cualing H, Steele P, et al. Progression of cutaneous B-cell pseudolymphoma to cutaneous B-cell lymphoma[J]. J Cutan Med Surg, 2002, 6(6): 519-528.
3[3]Gilliam AC, Wood GS. Cutaneous lymphoid hyperplasias[J].Semin Cutan Med Surg, 2000, 19(2): 133-41.
4[4]Kerl H, Fink-Puches R, Cerroni L. Diagnostic criteria of primary cutaneous B-cell lymphomas and pseudolymphomas [J].Keio J Med, 2001, 50(4): 269-273.
5[5]Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer[J]. Blood, 1997, 90(1): 354-371.
6[6]Baldassano MF, Bailey EM, Ferry JA, et al. Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features [J]. Am J Surg Pathol, 1999, 23(1): 88-96.
7[7]Fitzpatrick TB, Eisen AZ, Wollf K, et al. Dermatology In General Medicine[M]. 4th ed. USA: McGraw-Hill, Inc, 1993. 1320-1321.
8[8]Murphy M, Fullen D, Carlson JA. Low CD7 expression in benign and malignant cutaneous lymphocytic infiltrates: experience with an antibody reactive with paraffin-embedded tissue [J]. Am J Dermatopathol, 2002, 24(1): 6-16.
9[9]Kamarashev J, Schaerer L, Burg G, et al. Tumor-infiltrating T cells in primary cutaneous B-cell lympho-proliferative disorders[J]. J Cutan Pathol, 2001, 28(9): 448-452.
10[10]de Leval L, Harris NL, Longtine J, et al. Cutaneous B-cell lymphomas of follicular and marginal zone types: use of Bcl-6,CD10, Bcl-2, and CD21 in differential diagnosis and classification[J]. Am J Surg Pathol, 2001, 25(6): 732-741.
